日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  Mono-allelic expression of the IGF-I receptor does not affect IGF responses in human fibroblasts

Hammer, E., Kutsche, K., Haag, F., Ullrich, K., Sudbrak, R., Willig, R. P., Braulke, T., & Kubler, B. (2004). Mono-allelic expression of the IGF-I receptor does not affect IGF responses in human fibroblasts. European Journal of Endocrinology, 151(4), 521-529. doi:10.1530/eje.0.1510521.

Item is

基本情報

表示: 非表示:
資料種別: 学術論文
その他のタイトル : Eur J Endocrinol

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Hammer, E., 著者
Kutsche, K., 著者
Haag, F., 著者
Ullrich, K., 著者
Sudbrak, R.1, 著者           
Willig, R. P., 著者
Braulke, T., 著者
Kubler, B., 著者
所属:
1Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433550              

内容説明

表示:
非表示:
キーワード: -
 要旨: OBJECTIVE: It has been suggested that mono-allelic deletion of the IGF-I receptor gene is causally related to severe intrauterine and postnatal growth deficiency whereas no IGF-I resistance was observed in the patients' fibroblasts. The expression and regulation of the growth-modulating IGF binding proteins (IGFBPs) have been investigated in serum and fibroblasts of a short girl with mono-allelic loss of the distal long arm of chromosome 15 (15q26.1-qter). PATIENT AND METHODS: The mono-allelic loss of the IGF-I receptor (IGF1R) gene was confirmed in a child with prenatal and severe postnatal growth retardation by fluorescence in situ hybridization, and was evaluated on the protein level in fibroblasts of the patient by FACS analysis and IGF cross-linkage. Additionally, expression of IGFBPs and cell-mediated degradation of IGFBP-3 were examined in the patient's fibroblasts. RESULTS: Levels of GH, IGF-I, and IGFBP-3 were above the 95th percentile in the serum of the 3-year-old girl with a mono-allelic deletion of the IGF1R gene, suggesting IGF-I resistance. In the patient's fibroblasts the IGF-I receptor concentration was half that in control cells. Whereas the pattern of secreted IGFBPs in response to IGFs was not altered, the abundance of secreted IGFBPs was higher in the patient's cells than in controls. Moreover, fibroblast-mediated degradation of 125I-labeled IGFBP-3 appears to be reduced in the patient's fibroblasts. The higher abundance of IGFBPs in the patient's fibroblasts might be responsible for the lack of IGF-I-stimulated [alpha-1-14C]methylaminoisobutyric acid transport. CONCLUSION: Our results suggest that the expression and regulation of IGFBPs in tissues from patients with mono-allelic deletion of the IGF-I receptor gene may lead to IGF sequestration and contribute to IGF-I resistance and growth retardation.

資料詳細

表示:
非表示:
言語: eng - English
 日付: 2004-10
 出版の状態: 出版
 ページ: -
 出版情報: -
 目次: -
 査読: -
 識別子(DOI, ISBNなど): eDoc: 230217
DOI: 10.1530/eje.0.1510521
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: European Journal of Endocrinology
  出版物の別名 : Eur J Endocrinol
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: -
ページ: - 巻号: 151 (4) 通巻号: - 開始・終了ページ: 521 - 529 識別子(ISBN, ISSN, DOIなど): ISSN: 0804-4643